Clinical Trial Update: Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose nivolumab in combination with AVD as frontline therapy for classic Hodgkin's lymphoma; current status and efficacy/sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Hodgkin Lymphoma

Drugs mentioned

• AVD (doxorubicin, vinblastine, dacarbazine)
• nivolumab (nivolumab)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Safety Issues, Efficacy, Self | Phase 2 | Status: UNKNOWN